Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) is currently trading at $761.85. The stock has a 52-week range of $481.15 to $811.29 and a market capitalization of $80.54B.

Regeneron Pharmaceuticals, Inc. has a P/E ratio of 18.4 (forward P/E: 14.5), a dividend yield of 0.49%, and 1-year performance of +25.4%. 3 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

There have been 73 insider transactions for REGN in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

Regeneron Pharmaceuticals, Inc. (REGN) has returned +25.4% over the past 12 months. The stock traded between $481.15 and $811.29 during this period, and is currently at $761.85.

3 tracked hedge funds currently hold REGN in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

Regeneron Pharmaceuticals, Inc. (REGN) has a market capitalization of $80.54B. The trailing P/E ratio is 18.4 and forward P/E is 14.5. The stock is classified in the Healthcare sector.

Regeneron Pharmaceuticals, Inc. reported revenue of $14.34B with net income of $4.50B and a profit margin of 0.31%. The stock has a beta of 0.40.

Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector. It is held by 3 tracked hedge funds. See the ownership table above for the complete list.